Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases DOI Creative Commons
Ling Wang, Xiaoyan Zhang,

Ziyi Yang

et al.

Translational Neurodegeneration, Journal Year: 2024, Volume and Issue: 13(1)

Published: Dec. 6, 2024

Abstract Extracellular vesicles (EVs) are membrane originating from different cells within the brain. The pathophysiological role of EVs in neurodegenerative diseases is progressively acknowledged. This field has advanced basic biological research to essential clinical significance. capacity selectively enrich specific subsets biofluids via distinctive surface markers opened new avenues for molecular understandings across various tissues and organs, notably In recent years, brain-derived have been extensively investigated as biomarkers, therapeutic targets, drug-delivery vehicles diseases. review provides a brief overview characteristics physiological functions classes EVs, focusing on mechanisms by which types mediate occurrence development Concurrently, novel approaches challenges use delivery delineated.

Language: Английский

Autophagy‐associated non‐coding RNAs: Unraveling their impact on Parkinson's disease pathogenesis DOI Creative Commons
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal

et al.

CNS Neuroscience & Therapeutics, Journal Year: 2024, Volume and Issue: 30(5)

Published: May 1, 2024

Parkinson's disease (PD) is a degenerative neurological condition marked by the gradual loss of dopaminergic neurons in substantia nigra pars compacta. The precise etiology PD remains unclear, but emerging evidence suggests significant role for disrupted autophagy-a crucial cellular process maintaining protein and organelle integrity.

Language: Английский

Citations

18

Autophagy in Parkinson’s Disease DOI Creative Commons

Lior Nechushtai,

Dan Frenkel, Ronit Pinkas‐Kramarski

et al.

Biomolecules, Journal Year: 2023, Volume and Issue: 13(10), P. 1435 - 1435

Published: Sept. 22, 2023

Parkinson’s disease (PD) is a devastating associated with accumulation of α-synuclein (α-Syn) within dopaminergic neurons, leading to neuronal death. PD characterized by both motor and non-motor clinical symptoms. Several studies indicate that autophagy, an important intracellular degradation pathway, may be involved in different neurodegenerative diseases including PD. The autophagic process mediates the protein aggregates, damaged unneeded proteins, organelles, allowing their clearance, thereby maintaining cell homeostasis. Impaired autophagy cause abnormal proteins. Incomplete or impaired explain neurotoxic aggregates several Indeed, have suggested contribution α-Syn accumulation, death neuroinflammation. In this review, we summarize recent literature on involvement pathogenesis.

Language: Английский

Citations

32

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease DOI Open Access
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 25(1), P. 360 - 360

Published: Dec. 26, 2023

Parkinson’s disease (PD) is a complex neurodegenerative characterized by the progressive loss of dopaminergic neurons in substantia nigra and widespread accumulation alpha-synuclein (αSyn) protein aggregates. αSyn aggregation disrupts critical cellular processes, including synaptic function, mitochondrial integrity, proteostasis, which culminate neuronal cell death. Importantly, pathology extends beyond neurons—it also encompasses spreading throughout environment internalization microglia astrocytes. Once internalized, glia can act as neuroprotective scavengers, limit spread αSyn. However, they become reactive, thereby contributing to neuroinflammation progression PD. Recent advances research have enabled molecular diagnosis PD accelerated development targeted therapies. Nevertheless, despite more than two decades research, mechanisms, induction damage remain incompletely understood. Unraveling interplay between αSyn, neurons, may provide insights into initiation progression, bring us closer exploring new effective therapeutic strategies. Herein, we an overview recent studies emphasizing multifaceted nature its impact on both neuron glial damage.

Language: Английский

Citations

22

ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease DOI
Riya Thapa, Ehssan Moglad, Muhammad Afzal

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 98, P. 102327 - 102327

Published: May 10, 2024

Language: Английский

Citations

14

A recognition of exosomes as regulators of epigenetic mechanisms in central nervous system diseases DOI Creative Commons

Shunxin Hu,

Lei Feng,

Zhonghong Yang

et al.

Frontiers in Molecular Neuroscience, Journal Year: 2024, Volume and Issue: 17

Published: March 11, 2024

Exosomes, vesicular structures originating from cells, participate in the conveyance of proteins and nucleic acids. Presently, centrality epigenetic modifications neurological disorders is widely acknowledged. Exosomes exert influence over various phenomena, thereby modulating post-transcriptional regulatory processes contingent upon their constituent makeup. Consequently, heightened attention directed toward exosomes as instigators alterations has burgeoned recent years. Notably, serve vehicles for delivering methyltransferases to recipient cells. More significantly, non-coding RNAs, particularly microRNAs (miRNAs), represent pivotal contents within exosomes, wielding capacity expression diverse factors cerebral milieu. The transfer these exosomal amidst brain encompassing neuronal cells microglia, assumes a critical role genesis progression disorders, also, this not limited it may deal with any human disease, such cancer, cardiovascular diseases. This review will concentrate on elucidating regulation exosome-induced events its subsequent ramifications A more profound comprehension involvement exosome-mediated contributes awareness etiology advancement afflictions.

Language: Английский

Citations

7

The regulatory role of miRNA and lncRNA on autophagy in diabetic nephropathy DOI
Siming Yu, Yue Li, Xinxin Lu

et al.

Cellular Signalling, Journal Year: 2024, Volume and Issue: 118, P. 111144 - 111144

Published: March 15, 2024

Language: Английский

Citations

7

Medicinal and food plant: Cistanches Herba, a potential therapeutic hope for Parkinson’s disease and related complications DOI Creative Commons
Guoxue Zhu, Chengcheng Xu, Shujun Jiang

et al.

Journal of Agriculture and Food Research, Journal Year: 2025, Volume and Issue: unknown, P. 101671 - 101671

Published: Jan. 1, 2025

Language: Английский

Citations

0

Advances in autophagy for Parkinson’s disease pathogenesis and treatment DOI Open Access
Xiaojie Zhang, Huan Zhang, Jie Dong

et al.

Ageing and Neurodegenerative Diseases, Journal Year: 2025, Volume and Issue: 5(1)

Published: March 18, 2025

Autophagy is a cellular process essential for maintaining neuronal homeostasis by degrading and recycling damaged organelles proteins. Impairments in canonical autophagy pathways, such as macroautophagy, chaperone-mediated (CMA), mitophagy, are linked to Parkinson’s disease (PD) pathogenesis, contributing α-synuclein aggregation dopaminergic loss. Moreover, the recent discovery of noncanonical highlights unexpected roles autophagy-related proteins protein degradation beyond pathways. Advances understanding molecular mechanisms provide potential therapeutic strategies modulate this pathway PD. Key targets include mTOR AMPK, with compounds like rapamycin, trehalose, resveratrol showing promise preclinical models. Enhancing lysosomal function mitophagy also presents viable strategy alleviate PD symptoms. This review emphasizes complex modulation promising treating disease.

Language: Английский

Citations

0

Dopamine‐conjugated extracellular vesicles induce autophagy in Parkinson's disease DOI Creative Commons
Jae Hoon Sul, Sol Shin, Hark Kyun Kim

et al.

Journal of Extracellular Vesicles, Journal Year: 2024, Volume and Issue: 13(12)

Published: Dec. 1, 2024

Abstract The application of extracellular vesicles (EVs) as vehicles for anti‐Parkinson's agents represents a significant advance, yet their clinical translation is hampered by challenges in efficient brain delivery and complex blood‐brain barrier (BBB) targeting strategies. In this study, we engineered dopamine onto the surface adipose‐derived stem cell EVs (Dopa‐EVs) utilizing facile, two‐step cross‐linking approach. This engineering enhanced neuronal uptake primary neurons neuroblastoma cells, process shown to be competitively inhibited pretreatment receptor antibodies. Notably, Dopa‐EVs demonstrated increased accumulation mouse Parkinson's disease (PD) models. Therapeutically, administration led rescue dopaminergic loss amelioration behavioural deficits both 6‐hydroxydopamine (6‐OHDA) α‐Syn PFF‐induced PD Furthermore, observed that stimulated autophagy evidenced upregulation Beclin‐1 LC3‐II. These findings collectively indicate modification with presents potent strategy brain. remarkable therapeutic potential Dopa‐EVs, models, positions them highly promising candidate treatment, offering advance over current modalities.

Language: Английский

Citations

3

Functional implications of NHR-210 enrichment in C. elegans cephalic sheath glia: insights into metabolic and mitochondrial disruptions in Parkinson's disease models DOI Creative Commons
Rohil Hameed,

Anam Naseer,

Ankit Saxena

et al.

Cellular and Molecular Life Sciences, Journal Year: 2024, Volume and Issue: 81(1)

Published: May 1, 2024

Abstract Glial cells constitute nearly half of the mammalian nervous system's cellular composition. The glia in C. elegans perform majority tasks comparable to those conducted by their equivalents. cephalic sheath (CEPsh) glia, which are known be counterparts astrocytes, enriched with two nuclear hormone receptors (NHRs)—NHR-210 and NHR-231. This unique enrichment makes CEPsh these NHRs intriguing subjects study concerning neuronal health. We endeavored assess role neurodegenerative diseases related functional processes, using transgenic expressing human alpha-synuclein. employed RNAi-mediated silencing, followed behavioural, functional, metabolic profiling relation suppression NHR-210 231. Our findings revealed that depleting nhr-210 changes dopamine-associated behaviour mitochondrial function alpha synuclein-expressing strains NL5901 UA44, through a putative target, pgp-9 , transmembrane transporter. Considering alteration involvement transporter, we performed metabolomics via HR-MAS NMR spectroscopy. Remarkably, substantial modifications ATP, betaine, lactate, glycine levels were seen upon absence . also detected considerable pathways such as phenylalanine, tyrosine, tryptophan biosynthesis metabolism; glycine, serine, threonine well glyoxalate dicarboxylate metabolism. In conclusion, deficiency receptor alpha-synuclein strain results altered function, coupled alterations vital metabolite levels. These underline physiological importance glia. Graphical abstract

Language: Английский

Citations

2